ASEP Medical Holdings Inc (TSE:ASEP) has released an update.
Asep Medical Holdings Inc. has announced that their SepsetER AI-based diagnostic technology successfully differentiates between simple and perforated appendicitis in children, which is crucial for timely treatment due to the latter’s higher mortality risk. This innovation, stemming from a clinical study published in JAMA Pediatrics, indicates that the test could improve emergency diagnosis and management of pediatric appendicitis. Asep Medical, which focuses on novel solutions for severe sepsis and antibiotic failure, anticipates that this technology will enhance outcomes for children with appendicitis.
For further insights into TSE:ASEP stock, check out TipRanks’ Stock Analysis page.
